EXAS vs OSG · rev $2.76B vs rev $187.2M
EXACT Sciences Corporation (EXAS) versus Octave Specialty Group, Inc. (OSG) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Octave Specialty Group, Inc. (OSG) is a insurance - specialty company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported OSG revenue for 2026-06-30 was $187.2M. Net income was -$15.0M. Revenue was up 79.7% from 2026-03-31 to 2026-06-30. OSG currently screens at market cap $260.2M.
EXAS currently screens at market cap $20.03B. OSG currently screens at market cap $260.2M.
Not investment advice. Open the EXAS and OSG stock pages for the full models.
Not investment advice.